Last update Oct. 9, 2016
Very Low Risk
Antihistamine for topical use both on nose and eye.
Plasma concentrations reached are very low and, according to the manufacturer, it is excreted into breastmilk in clinically non-significant amount at 0.3 to 0.6% of maternal dose: 1.5 to 3 micrograms.
As in most ophthalmic and nasal topically used preparations, the tiny dose and poor levels in the blood, render it compatible with breastfeeding.
We do not have alternatives for Λεβοκαβαστίνη υδροχλωρική since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2015 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM